Virtually all of the scientific authors who provided positive results for the anti-diabetic drug rosiglitazone had financial relationships with pharmaceutical companies, according to new research.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Health
- Americans find doing their own taxes simpler than improving diet and health
- Neuropeptide Y2 Receptor (NPY2R) Expression in Saliva Predicts Feeding Immaturity in the Premature Neonate
- Tinnitus Severity Is Reduced with Reduction of Depressive Mood – a Prospective Population Study in Sweden
- Deep Brain Stimulation of Nucleus Accumbens Region in Alcoholism Affects Reward Processing
- The Role of Attention in Ambiguous Reversals of Structure-From-Motion